Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | ARGX | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 58.6575 | 749.09 | 815.35 | ||
| High | 58.9900 | 749.09 | 818.78 | ||
| Low | 58.0192 | 726.43 | 795.02 | ||
| Latest | 58.9900 | 733.04 | 800.01 | ||
| Change | +0.4460 | -8.88 | -13.23 | ||
| % Change | +0.76% | -1.20% | -1.63% | ||
| Volume | 84,600 | 1,682,500 | 440,200 | ||
| 20-Day Average Volume | 135,930 | 883,075 | 335,840 | ||
| Previous Close | 58.5440 | 741.92 | 813.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.2662 | 772.91 | 824.09 | ||
| 20-Day Raw Stochastic | 64.82% | 6.98% | 31.74% | ||
| 20-Day Relative Strength | 48.79 | 47.04 | 40.72 | ||
| Weighted Alpha | -32.98 | +17.51 | +28.12 | ||
| Today's Opinion | 72% Sell | 56% Buy | 24% Buy | ||
| Previous Opinion | 88% Sell | 80% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.79% since 01/09/26 | -7.97% since 01/09/26 | +1.46% since 01/09/26 | ||
| Low | 57.6100 on 01/14/26 | 726.43 on 01/16/26 | 770.67 on 01/12/26 | ||
| High | 60.9600 on 01/12/26 | 811.09 on 01/12/26 | 818.78 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +0.29% since 12/16/25 | -1.78% since 12/16/25 | -6.04% since 12/16/25 | ||
| Low | 55.3600 on 01/06/26 | 726.43 on 01/16/26 | 770.67 on 01/12/26 | ||
| High | 60.9600 on 01/12/26 | 821.11 on 01/09/26 | 878.19 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | -17.70% since 10/16/25 | +28.79% since 10/16/25 | -4.45% since 10/16/25 | ||
| Low | 54.1000 on 10/29/25 | 566.11 on 10/17/25 | 749.75 on 10/30/25 | ||
| High | 72.5700 on 10/22/25 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | -27.18% since 07/16/25 | +33.78% since 07/16/25 | +38.43% since 07/16/25 | ||
| Low | 54.1000 on 10/29/25 | 541.00 on 10/13/25 | 560.91 on 07/21/25 | ||
| High | 89.7100 on 07/29/25 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 57,238,176 | 77,041,760 | 49,255,816 | ||
| Shares Outstanding, K | 970,303 | 105,099 | 61,569 | ||
| Annual Sales | 15,558,000,000 | 14,202,000,000 | 2,252,040,000 | ||
| Annual Net Income | 3,002,000,000 | 4,412,600,000 | 833,040,000 | ||
| Last Quarter Sales | N/A | 3,754,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | N/A | 1,460,000,000 | 344,260,000 | ||
| 60-Month Beta | 0.77 | 0.39 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 11.83 on 10/28/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 08/19/25 | 01/30/26 | 02/26/26 | ||
| Most Recent Dividend | 0.760 on 09/10/25 | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | 09/10/25 | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 62.17 | ||